{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:03:55Z","timestamp":1790967835377,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/bf01078484","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T02:31:42Z","timestamp":1107225102000},"page":"143-152","source":"Crossref","is-referenced-by-count":32,"title":["Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors"],"prefix":"10.1007","volume":"24","author":[{"given":"Damayanthi","family":"Devineni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Klein-Szanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/archneur.1975.00490540029003","volume":"32","author":"VA Levin","year":"1975","unstructured":"Levin VA, Freeman-Dove M, Landahl HD: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 32: 785?791, 1975","journal-title":"Arch Neurol"},{"key":"CR2","first-page":"70","volume":"13","author":"RG Blasberg","year":"1986","unstructured":"Blasberg RG, Groothuis DR: Chemotherapy of brain tumors: physiological and pharmacokinetic consideration. Seminar in Oncology 13: 70?82, 1986","journal-title":"Seminar in Oncology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0733-8619(18)30292-5","volume":"9","author":"PC Phillips","year":"1991","unstructured":"Phillips PC: Antineoplastic drug resistance in brain tumors. Neurologic Clinics 9: 383?404, 1991","journal-title":"Neurologic Clinics"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0006-2952(92)90443-M","volume":"44","author":"C Cuvier","year":"1992","unstructured":"Cuvier C, Roblot-Treupel L, Millot J, Lizard G, Chevillard S, Manfait M, Couvreur P, Poupou MF: Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem Pharmacol 44: 509?517, 1992","journal-title":"Biochem Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/jnci\/84.10.804","volume":"84","author":"GH Mickisch","year":"1992","unstructured":"Mickisch GH, Rahman A, Pastan I, Gottesman M: Increased effectiveness of liposomal-encapsulated doxorubicin in multidrug-resistant-transgenic mice compared with free doxorubicin. J Natl Cancer Inst 84: 804?805, 1992","journal-title":"J Natl Cancer Inst"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-1-4615-7255-8_17","volume-title":"Implications of the blood-brain barrier and its manipulation","author":"JS Kroin","year":"1989","unstructured":"Kroin JS, Penn DR: Implantable pumps to deliver drugs directly into the CNS. In: Neuweld EA (ed) Implications of the blood-brain barrier and its manipulation, Plenum Publ Corp, New York 601?620, 1989"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","volume":"74","author":"H Brem","year":"1991","unstructured":"Brem H, Mahaley MS, Vick NA, Black KL, Schold Jr SC, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74: 441?446, 1991","journal-title":"J Neurosurg"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1200\/JCO.1991.9.9.1580","volume":"9","author":"EA Neuwelt","year":"1991","unstructured":"Neuwelt EA, Goldman D, Dahlborg SA, Crossen J, Ramsey Fet al.: Primary CNS lymphoma treated with osmotic bloodbrain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580?1590, 1991","journal-title":"J Clin Oncol"},{"key":"CR9","first-page":"1571","volume":"47","author":"NH Greig","year":"1987","unstructured":"Greig NH, Momma S, Sweetney DJ, Smith QR, Rapoport SI: Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res 47: 1571?1576, 1987","journal-title":"Cancer Res"},{"key":"CR10","first-page":"66","volume":"259","author":"WM Pardridge","year":"1991","unstructured":"Pardridge WM, Buciak JL, Friden PM: Selective transport of an antitransferrin receptor antibody through the bloodbrain barrierin vivo. J Pharmacol Exp Ther 259: 66?70, 1991","journal-title":"J Pharmacol Exp Ther"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","volume":"88","author":"PM Friden","year":"1991","unstructured":"Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Sturzyk RM: Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci USA 88: 4771?4775, 1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/jps.2600791102","volume":"79","author":"PK Gupta","year":"1990","unstructured":"Gupta PK: Drug targeting in cancer chemotherapy: a clinical perspective. J Pharm Sci 79: 949?962, 1990","journal-title":"J Pharm Sci"},{"key":"CR13","first-page":"233","volume":"3","author":"SF Douglas","year":"1986","unstructured":"Douglas SF, Davis SS, Ilium L: Nanoparticles in drug delivery. CRC Crit Rev Ther Drug Carrier Sys 3: 233?261, 1986","journal-title":"CRC Crit Rev Ther Drug Carrier Sys"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/10611869308998759","volume":"1","author":"EE Hassan","year":"1993","unstructured":"Hassan EE, Gallo JM: Targeting anticancer drug to the brain, I: Enhanced brain delivery of oxantrazole following administration in magnetic chitosan microspheres. J Drug Targeting 1: 7?14, 1993","journal-title":"J Drug Targeting"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00165526","volume":"11","author":"RD Fross","year":"1991","unstructured":"Fross RD, Warnke PC, Groothuis DR: Blood flow and blood to tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research. J Neuro-Oncol 11: 185?197, 1991","journal-title":"J Neuro-Oncol"},{"key":"CR16","first-page":"279","volume-title":"Cellular Pathology Techniques","author":"CFA Culling","year":"1985","unstructured":"Culling CFA: Endogenous pigments. In: Culling CFA, Allison RT, Bair WT (eds) Cellular Pathology Techniques, Butterworths, London pp 279, 1985"},{"key":"CR17","unstructured":"CoMOS, Version 6.03, Bio-Rad Microscience Ltd., Hercules, CA, 1991"},{"key":"CR18","first-page":"325","volume-title":"Drug Delivery Devices","author":"DF Ranney","year":"1988","unstructured":"Ranney DF: Magnetically controlled devices and biomodulation. In: Tyle P (ed) Drug Delivery Devices, Marcel Dekker, New York 325?368, 1988"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1248\/bpb1978.4.624","volume":"4","author":"Y Morimoto","year":"1981","unstructured":"Morimoto Y, Okumura MM, Sugibayashi K, Kalo Y: Biomedical applications of magnetic fields. II. Preparation and magnetic guidance of magnetic albumin microspheres for site specific drug deliveryin vivo. J Pharm Dyn 4: 624?631, 1981","journal-title":"J Pharm Dyn"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0277-5379(83)90408-X","volume":"19","author":"KJ Widder","year":"1983","unstructured":"Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AF: Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats. Eur J Cancer Clin Oncol 19: 135?140, 1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jps.2600780303","volume":"78","author":"JM Gallo","year":"1989","unstructured":"Gallo JM, Gupta PK, Hung CT, Perrier DG: Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J Pharm Sci 78: 190?194, 1989","journal-title":"J Pharm Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0277-5379(83)90409-1","volume":"19","author":"GA Poore","year":"1983","unstructured":"Poore GA, Senyei AE: Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: Ultrastructural evaluation of microsphere disposition. Eur J Cancer Clin Oncol 19: 141?148, 1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR23","first-page":"631","volume":"19","author":"H Ovadia","year":"1983","unstructured":"Ovadia H, Paterson PY, Hale JR: Magnetic microspheres as drug carriers: Factors influencing localization at different anatomical sites in rats. Israel J Med Sci 19: 631?637, 1983","journal-title":"Israel J Med Sci"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1023\/A:1015978704810","volume":"5","author":"JM Gallo","year":"1988","unstructured":"Gallo JM, Hassan EE: Receptor-mediated magnetic carriers: Basis for targeting. Pharm Res 5: 300?304, 1988","journal-title":"Pharm Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01078484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01078484\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01078484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T01:20:59Z","timestamp":1556328059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01078484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995]]}},"alternative-id":["BF01078484"],"URL":"https:\/\/doi.org\/10.1007\/bf01078484","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995]]}}}